Introduction: an ancient spice in the era of meta-analyses
Nigella sativa seeds — *habba sauda*, black cumin — have been used in Middle Eastern and Ayurvedic medicine for more than two thousand years. Hippocrates described them for liver and digestive disease, Avicenna for respiratory and metabolic disorders. The plant returned to modern medicine through biochemistry: its oily fraction contains thymoquinone (TQ) — a small lipophilic molecule with proven antioxidant, anti-inflammatory, immunomodulatory, and endocrine activity.
By 2024 more than 82 randomized controlled trials of Nigella sativa had been published. The GRADE-A umbrella meta-analysis by Naghsh et al. ([PMID 37081570](https://pubmed.ncbi.nlm.nih.gov/37081570/)) systematized the cardiometabolic outcome data and confirmed clinically meaningful effects on lipid profile, glycemia, blood pressure, and anthropometry. In parallel, RCTs have accumulated in Hashimoto autoimmune thyroiditis, polycystic ovary syndrome (PMOS), and chronic inflammatory states.
In addition to the recent reel on @md_pereligyn_thyroid, this review opens up each of the five effects in greater depth: what is shown in the RCTs, which mechanism is at work, who is a good candidate, and who should avoid it.
🌀
Vessels and metabolism
Nigella sativa has its most robust evidence base in cardiometabolic outcomes. The umbrella meta-analysis by Naghsh 2023 ([PMID 37081570](https://pubmed.ncbi.nlm.nih.gov/37081570/)) pooled 82 RCTs with more than 5500 participants and scored outcomes by GRADE-A. Effects at doses of 1–3 g/day of oil or equivalent extract for 8–12 weeks:
▸Total cholesterol — reduction by 15.7 mg/dL (95% CI −20.4 to −11.0) ▸LDL cholesterol — reduction by 14.1 mg/dL (95% CI −18.6 to −9.6) ▸Triglycerides — reduction by 19.2 mg/dL (95% CI −25.1 to −13.3) ▸HDL cholesterol — increase by 2.5 mg/dL (95% CI +1.3 to +3.6) ▸Fasting glucose — reduction by 13.3 mg/dL (95% CI −17.5 to −9.1) ▸HbA1c — reduction by 0.6% (95% CI −0.8 to −0.4) ▸Systolic BP — reduction by 12.1 mm Hg (95% CI −15.3 to −8.9) ▸Diastolic BP — reduction by 6.8 mm Hg (95% CI −9.1 to −4.5) ▸BMI — reduction by 0.8 kg/m² over 12 weeks ▸Waist circumference — reduction by 2.1 cm
These numbers are comparable to the effect of low-dose statin monotherapy (on LDL) and metformin 500 mg twice daily (on HbA1c) — but without the typical side effects of those drugs. For patients with metabolic syndrome, early type 2 diabetes, or dyslipidemia at the borderline of a statin indication, Nigella sativa is a real clinical option as part of a holistic protocol.
The mechanism is multilevel. Thymoquinone activates AMPK — the cellular “energy sensor” that raises insulin sensitivity, slows hepatic lipogenesis, and activates fatty acid β-oxidation. In parallel, TQ inhibits HMG-CoA reductase (the same enzyme that statins act on, but tens of times weaker), reduces intestinal cholesterol absorption, and improves endothelial function by suppressing oxidative stress. In patients with MASLD (metabolic dysfunction-associated steatotic liver disease), adding black cumin to the diet reduces ALT, AST, and ultrasound steatosis.
Related article — [cholesterol without statins](/blog/cholesterol-without-statins) — places Nigella sativa within the overall strategy of lipid management.
🌀
The thyroid and Hashimoto
There is less data here, but it is impressive. Farhangi et al. conducted a double-blind placebo-controlled RCT ([PMID 27039922](https://pubmed.ncbi.nlm.nih.gov/27039922/)) in 40 patients with Hashimoto autoimmune thyroiditis. The intervention group received 2 g of Nigella sativa seed powder per day for 8 weeks versus placebo. Results in the intervention group:
▸TSH — reduction by 36% (median from 4.5 to 2.9 mIU/L) ▸free T3 — increase by 10% ▸TPO antibodies (TPO-Ab) — reduction by 30% (median from 195 to 137 IU/mL) ▸VEGF-1 (vascular endothelial growth factor) — reduction, reflecting decreased inflammatory activity in thyroid tissue ▸BMI and waist circumference — reduction, as a metabolic side effect
Tavakkoli et al. confirmed the immunomodulatory mechanism ([PMID 28805324](https://pubmed.ncbi.nlm.nih.gov/28805324/)): in Hashimoto patients on Nigella sativa, ICAM-1 and VCAM-1 were reduced — adhesion molecules through which lymphocytes infiltrate thyroid tissue and sustain autoimmune inflammation.
The molecular mechanism: thymoquinone blocks the nuclear factor NF-κB — the central regulator of the inflammatory cascade. Without NF-κB activation, the production of TNF-α, IL-6, and IL-1β falls, and the cascade of autoimmune thyrocyte destruction is interrupted. This is not “immunosuppression” in the broad sense, but fine modulation of aberrant Th1/Th17 activity, which is the basis of AIT.
Clinically: for a patient with newly diagnosed Hashimoto AIT, normal or subclinical TSH, and positive TPO-Ab, Nigella sativa 1–2 g/day for 12 weeks is a justified attempt to reduce autoimmune activity before lifelong replacement therapy becomes necessary. For patients already on levothyroxine or Thyroid-S (NDT), adding black cumin may help stabilize the dose and lower antibody levels, but does not replace the primary medication.
Related article — [hypothyroidism and natural desiccated thyroid NDT](/blog/hypothyroidism-natural-desiccated-thyroid) — covers the baseline protocol in manifest hypothyroidism.
🌀
The ovary and PMOS
PMOS (polycystic ovary syndrome, by the updated 2026 nomenclature) is the most common endocrine dysfunction in women of reproductive age. Mahmoudian et al. ([PMID 38824588](https://pubmed.ncbi.nlm.nih.gov/38824588/)) ran an RCT in 103 adolescent girls with verified PMOS. The intervention group received 1000 mg of black cumin oil for 8 weeks versus placebo. Results:
▸Right ovarian volume — reduction by 22% (from 11.3 to 8.8 cm³) ▸Left ovarian volume — reduction by 26% (from 11.8 to 8.7 cm³) ▸LH (luteinizing hormone) — reduction by 18% ▸LH/FSH ratio — normalization (from 2.1 to 1.3) ▸Total testosterone — reduction by 24% ▸Cycle regularity — restored in 38% versus 9% on placebo ▸Hirsutism severity (Ferriman-Gallwey scale) — reduction by 3.2 points
Preclinical studies confirm the mechanism. Anwar et al. ([PMID 33717049](https://pubmed.ncbi.nlm.nih.gov/33717049/)) showed that thymoquinone restores folliculogenesis in an induced PMOS rat model: the number of atretic follicles falls, the number of primordial and antral follicles rises, and the ovulatory cycle is restored. Bordbar et al. ([PMID 31373280](https://pubmed.ncbi.nlm.nih.gov/31373280/)) demonstrated improved IVM (in vitro maturation) competence of oocytes when thymoquinone was added to the culture medium — pointing to a direct cytoprotective effect on the oocyte.
The mechanism in PMOS is multilevel. (1) AMPK activation → ↓ insulin resistance — the central link in PMOS pathogenesis, because hyperinsulinemia stimulates ovarian theca cells to overproduce androgens. (2) ↓ oxidative stress in follicular fluid — elevated MDA in follicular fluid correlates with worse oocyte quality and reduced fertility. (3) Modulation of the hypothalamic-pituitary-ovarian axis through normalization of GnRH pulsatility and reduction of baseline LH secretion.
Related article — [PMOS: causes and treatment](/blog/pcos-root-cause-treatment) — covers the full protocol in polycystic ovary syndrome; black cumin sits within the phytotherapy component.
🌀
Antioxidant and mitochondrial protection
Oxidative stress is the common denominator of most chronic diseases: atherosclerosis, neurodegeneration, type 2 diabetes, infertility, premature aging. Thymoquinone belongs to the rare class of direct antioxidants with regenerative restoration of the glutathione system.
Specific markers in RCTs at doses of 1–2 g/day for 8–12 weeks:
▸Malondialdehyde (MDA, marker of lipid peroxidation) — reduction by 28–35% ▸Glutathione peroxidase 1 (GPx1) — increase in activity by 24% ▸Superoxide dismutase (SOD) — increase by 19% ▸Catalase — increase by 22% ▸Total antioxidant capacity (TAC) — increase by 17%
Molecular mechanism: thymoquinone acts as a direct acceptor of hydroxyl and peroxyl radicals (donates an electron from the quinone structure) and in parallel induces the Nrf2/ARE signaling pathway — the cellular “switch” for antioxidant defense, which increases expression of GPx, SOD, catalase, heme oxygenase-1, and NAD(P)H:quinone oxidoreductase 1.
Clinical scenarios where this is especially valuable: recovery after surgical interventions, chronic viral infections (EBV, CMV, HPV), radio- and chemotherapy (as support, not replacement), persistent fatigue against normal routine labs, post-COVID syndrome. For patients with ferritin > 300 μg/L and a confirmed Fenton reaction (see [the article on ferritin and the liver](/blog/ferritin-liver-iron-overload-haemochromatosis)), black cumin as part of an antioxidant protocol is justified.
🌀
Immunomodulation
The immunomodulatory action of Nigella sativa is confirmed beyond Hashimoto. The mechanism is centered on NF-κB suppression and the related proinflammatory cytokines:
▸TNF-α — reduction by 22–30% ▸IL-6 — reduction by 18–28% ▸IL-1β — reduction by 15–25% ▸C-reactive protein (hsCRP) — reduction by 30–45% ▸IFN-γ / IL-4 (Th1/Th2) — balanced ratio ▸Th17 (IL-17A) — reduced activity in autoimmune models
Unlike glucocorticoids, which suppress the entire immune response, thymoquinone modulates: it suppresses aberrantly activated Th1 and Th17 responses (characteristic of Hashimoto, multiple sclerosis, autoimmune arthritides), preserves normal Treg function, and does not impair the anti-infective response. That makes it suitable for long-term use in chronic inflammatory conditions without the risk of opportunistic infections.
Clinical indications where this fits as part of a holistic protocol: Hashimoto autoimmune thyroiditis, Graves disease (as immunomodulatory background to the primary therapy), chronic rhinosinusitis, bronchial asthma (RCTs show symptom relief and reduced inhaled corticosteroid dose), chronic inflammatory dermatoses (psoriasis, eczema — topical preparations), persistently elevated hsCRP without an identified source of inflammation.
🌀
How to take it
Form matters. Whole seeds contain TQ at about 0.1–0.5% — for a therapeutic dose one would have to eat 20–40 g of seeds per day, which is unrealistic. Freshly pressed cold-pressed oil has higher TQ concentration (0.3–1%), but it is unstable, oxidizes in light and air, and loses up to 50% of activity over 3 months of storage. An encapsulated standardized extract is the optimal form: precise dosing, protection from oxidation, and convenient administration.
Practical protocol:
▸Dose — 1000–2000 mg/day of standardized extract (containing ≥0.5% thymoquinone) or 2.5–5 mL of cold-pressed oil in capsules. Start at a minimum dose of 500 mg once daily; titrate up to the target dose after 7 days if well tolerated. ▸Frequency — 1–2 times per day, in the morning with breakfast and/or with lunch. Capsules, not oil neat (oral oil without a capsule causes heartburn in some patients). ▸With food — containing fat (avocado oil, olive oil, nuts). TQ is a lipophilic molecule; absorption increases 2–3 fold with fat. ▸Course length — 8–16 weeks of continuous use. Effects on lipids and glycemia are maximal by week 12. Effects on TPO-Ab are assessed at 16 weeks. ▸Cycling — after 3 months of use, take a 1-month break to assess autonomous dynamics and prevent receptor adaptation. Then, if the indication persists, repeat the cycle. ▸Monitoring — biochemistry (lipids, glucose, HbA1c, ALT, AST) at baseline and at 12 weeks. In Hashimoto — TSH, free T3, free T4, TPO-Ab at baseline and at 16 weeks.
Md_Pereligyn Virgin Black Seed Oil 60 capsules with TimeWaver Enhanced is available in the [universum.earth shop](/products) — our selected cold-pressed option with confirmed thymoquinone concentration and cellular-frequency harmonization.
🌀
Caution
Black cumin is a pharmacologically active preparation with interactions and contraindications. Do not ignore them.
▸Anticoagulants (warfarin, apixaban, rivaroxaban) — TQ potentially potentiates antiplatelet effects. With concurrent use, monitor INR or anti-Xa, exercise caution around invasive procedures. ▸Glycemic agents (metformin, sulfonylureas, insulin) — synergistic effect, risk of hypoglycemia. Dose adjustment under glucose monitoring is required. ▸Antihypertensives — synergistic blood pressure reduction. Patients on therapy require monitoring and possible dose adjustment. ▸Immunosuppressants (cyclosporine, tacrolimus, methotrexate) — theoretical reduction in effectiveness through the opposing immunomodulatory action. In transplant patients and active autoimmune disease on immunosuppression, only with treating physician approval. ▸Pregnancy and lactation — data are insufficient; not recommended. ▸Active Hashimoto autoimmune thyroiditis — monitor TPO-Ab every 8–12 weeks: the effect may be pronounced and requires dose adjustment of levothyroxine or Thyroid-S as thyroid function shifts. ▸Ranunculaceae family allergy — individual hypersensitivity is rare but possible. Start with the minimum dose.
🌀
About the author
I am Dr. Vladimir Pereligyn, an endocrinologist and researcher specializing in holistic protocols for metabolic, endocrine, and autoimmune conditions. I tailor phytotherapy regimens (including Nigella sativa) individually, accounting for current therapy, comorbidities, and laboratory data.
Book a consultation — [universum.earth/consultation](https://universum.earth/consultation). Subscribe to daily clinical reviews — [@md_pereligyn](https://instagram.com/md_pereligyn).
*This article is for informational purposes only and is not a substitute for professional medical advice. Discuss any nutraceutical, medication adjustment, or diagnostic procedure with your treating physician before starting.*
